HERON THERAPEUTICS, INC. /DE/ — Director's Dealing 2023

Jul 20, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK: 0000818033
Period of Report: 2023-07-17

Reporting Person: Peraza Lisa (VP, Chief Accounting Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-17	Employee Stock Option (Right to Buy)	$1.32	A	150000	Acquired	2033-07-17	Common Stock (150000)	Direct

Footnotes

F1: The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (07/17/2023).